Proactively manage your pharmacy inventory
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Manage your formulary budget
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Technetium-99m labeled polypeptides for imaging|
|Abstract:||The invention relates to radiolabeled imaging of a mammalian body. The invention in particular provides for reagents labeled with technetium-99m for such imaging. The invention provides peptides which bind technetium-99m and which can be targeted to specific sites within a mammalian body.|
|Inventor(s):||Dean; Richard T. (Bedford, NH)|
|Assignee:||Diatide, Inc. (Londonderry, NH)|
|Filing Date:||Jun 07, 1995|
|Claims:||1. A polypeptide reagent for preparing a scintigraphic imaging agent, the reagent comprising, in combination: |
(a) a specific binding peptide that specifically binds to a target site to be imaged; and
(b) a technetium binding moiety of the formula
wherein Cp is a protected cysteine amino acid residue and (aa) is any amino acid, the technetium binding moiety being covalently bound to the specific binding peptide, and wherein the reagent has an amino acid sequence of 6 to 100 amino acids.
2. A polypeptide reagent according to claim 1 wherein the specific binding peptide and the technetium binding moiety are covalently linked through from one to about ninety amino acids.
3. A polypeptide reagent according to claim 1 wherein the sidechain sulfur atom of the cysteine residue is protected by a protecting group of the formula
wherein R is lower alkyl having 1 to 6 carbon atoms, phenyl, or phenyl substituted with lower alkyl, hydroxy, lower alkoxy, carboxy, or lower alkoxycarbonyl, or 2-pyridyl, 3-pyridyl, or 4-pyridyl.
4. A polypeptide reagent according to claim 1 wherein the Cp(aa) Cp moiety has the formula:
5. A polypeptide reagent according to claim 1 wherein the specific binding peptide specifically binds to clots, tumors, sites of infection, atherosclerotic plaques, amyloid plaques or bone.
6. A polypeptide reagent according to claim 1 wherein the specific binding peptide is selected from the group consisting of:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.